Free Trial

Jennison Associates LLC Raises Stock Holdings in Agilent Technologies, Inc. (NYSE:A)

Agilent Technologies logo with Medical background

Jennison Associates LLC increased its stake in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) by 17.6% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 439,112 shares of the medical research company's stock after acquiring an additional 65,731 shares during the quarter. Jennison Associates LLC owned approximately 0.15% of Agilent Technologies worth $51,367,000 at the end of the most recent quarter.

Other large investors have also recently made changes to their positions in the company. Norges Bank bought a new stake in shares of Agilent Technologies in the fourth quarter valued at $456,963,000. GAMMA Investing LLC raised its holdings in shares of Agilent Technologies by 15,648.1% during the 1st quarter. GAMMA Investing LLC now owns 627,247 shares of the medical research company's stock valued at $73,375,000 after buying an additional 623,264 shares in the last quarter. Two Sigma Investments LP boosted its position in Agilent Technologies by 345.9% during the fourth quarter. Two Sigma Investments LP now owns 769,897 shares of the medical research company's stock valued at $103,428,000 after buying an additional 597,249 shares during the period. Iron Triangle Partners LP purchased a new stake in shares of Agilent Technologies during the fourth quarter valued at approximately $80,110,000. Finally, Marshall Wace LLP grew its stake in shares of Agilent Technologies by 280.3% in the fourth quarter. Marshall Wace LLP now owns 806,895 shares of the medical research company's stock worth $108,398,000 after purchasing an additional 594,744 shares during the last quarter. 87.42% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on A. UBS Group reduced their price objective on shares of Agilent Technologies from $150.00 to $130.00 and set a "neutral" rating for the company in a research note on Thursday, May 29th. TD Cowen raised their target price on Agilent Technologies to $150.00 and gave the stock a "buy" rating in a report on Thursday, May 29th. Leerink Partners boosted their price objective on Agilent Technologies to $135.00 and gave the company a "buy" rating in a research report on Friday, May 30th. Wall Street Zen raised shares of Agilent Technologies from a "hold" rating to a "buy" rating in a report on Saturday, June 28th. Finally, Robert W. Baird lowered their price objective on shares of Agilent Technologies from $159.00 to $140.00 and set an "outperform" rating for the company in a research report on Thursday, May 22nd. Six research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company's stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $139.77.

Check Out Our Latest Analysis on Agilent Technologies

Insider Activity

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,508 shares of the company's stock in a transaction on Tuesday, July 1st. The shares were sold at an average price of $117.44, for a total value of $177,099.52. Following the completion of the transaction, the chief executive officer owned 37,448 shares in the company, valued at $4,397,893.12. This represents a 3.87% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Company insiders own 0.26% of the company's stock.

Agilent Technologies Price Performance

NYSE:A traded up $3.44 during trading hours on Wednesday, reaching $119.63. 648,282 shares of the company were exchanged, compared to its average volume of 1,857,070. The company has a current ratio of 2.09, a quick ratio of 1.60 and a debt-to-equity ratio of 0.55. Agilent Technologies, Inc. has a twelve month low of $96.43 and a twelve month high of $153.84. The firm has a market cap of $33.98 billion, a PE ratio of 29.56, a price-to-earnings-growth ratio of 3.40 and a beta of 1.23. The stock's 50-day moving average is $116.04 and its 200-day moving average is $122.00.

Agilent Technologies (NYSE:A - Get Free Report) last released its quarterly earnings data on Wednesday, May 28th. The medical research company reported $1.31 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.26 by $0.05. The firm had revenue of $1.67 billion during the quarter, compared to analysts' expectations of $1.63 billion. Agilent Technologies had a net margin of 17.59% and a return on equity of 25.92%. Agilent Technologies's revenue was up 6.0% compared to the same quarter last year. During the same period last year, the business earned $1.22 earnings per share. On average, sell-side analysts anticipate that Agilent Technologies, Inc. will post 5.58 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, July 23rd. Shareholders of record on Tuesday, July 1st will be issued a dividend of $0.248 per share. The ex-dividend date is Tuesday, July 1st. This represents a $0.99 annualized dividend and a yield of 0.83%. Agilent Technologies's dividend payout ratio (DPR) is 24.44%.

Agilent Technologies Company Profile

(Free Report)

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.

Recommended Stories

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Should You Invest $1,000 in Agilent Technologies Right Now?

Before you consider Agilent Technologies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Agilent Technologies wasn't on the list.

While Agilent Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

3 Cheap Growth Stocks Set to Explode This Summer
3 Defense Stocks Under $10 With Massive Upside
3 Tech Stocks Insiders Are Buying: Speculative Plays for June

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines